Madrigal Pharmaceuticals IncNASDAQ:MDGL
- LAST PRICE222.5100
- TODAY'S CHANGE (%)-0.7800 (-0.3493%)
- Bid / Lots218.8000/ 1
- Ask / Lots226.4900/ 8
- Open / Previous Close220.5000 / 223.2900
- Day Range
- 52 Week Range
- Volume263,597
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDGL |
|---|---|---|
| 09:32 ET | 2063 | 220.595 |
| 09:34 ET | 100 | 219.9 |
| 09:39 ET | 100 | 222.84 |
| 09:41 ET | 300 | 220.29 |
| 09:43 ET | 600 | 219.99 |
| 09:45 ET | 300 | 219.84 |
| 09:52 ET | 300 | 220.455 |
| 09:54 ET | 200 | 221.64 |
| 09:56 ET | 529 | 221.72 |
| 09:59 ET | 1400 | 221.485 |
| 10:01 ET | 2200 | 221.755 |
| 10:03 ET | 100 | 221.775 |
| 10:12 ET | 200 | 222.155 |
| 10:14 ET | 100 | 221.86 |
| 10:17 ET | 271 | 221.06 |
| 10:19 ET | 205 | 220.86 |
| 10:21 ET | 650 | 220.2 |
| 10:24 ET | 1905 | 219.935 |
| 10:26 ET | 601 | 220.495 |
| 10:28 ET | 160 | 221.105 |
| 10:32 ET | 209 | 220.7 |
| 10:33 ET | 1030 | 220.46 |
| 10:35 ET | 499 | 221.45 |
| 10:37 ET | 1700 | 221.99 |
| 10:39 ET | 160 | 222.0407 |
| 10:42 ET | 150 | 221.665 |
| 10:46 ET | 600 | 222.385 |
| 10:48 ET | 200 | 222.61 |
| 10:50 ET | 100 | 222.965 |
| 10:53 ET | 100 | 223.63 |
| 11:00 ET | 300 | 223.5 |
| 11:02 ET | 125 | 224.5523 |
| 11:09 ET | 100 | 223 |
| 11:20 ET | 200 | 223.09 |
| 11:22 ET | 600 | 222.93 |
| 11:24 ET | 200 | 222.7 |
| 11:26 ET | 100 | 222.775 |
| 11:27 ET | 472 | 223.28 |
| 11:29 ET | 1200 | 223 |
| 11:31 ET | 100 | 222.85 |
| 11:36 ET | 100 | 222.61 |
| 11:44 ET | 200 | 222.81 |
| 11:45 ET | 109 | 222.755 |
| 11:47 ET | 200 | 222.15 |
| 11:49 ET | 200 | 221.79 |
| 11:56 ET | 100 | 221.55 |
| 11:58 ET | 100 | 221.6 |
| 12:00 ET | 200 | 221.425 |
| 12:02 ET | 200 | 221.165 |
| 12:03 ET | 5849 | 222.99 |
| 12:09 ET | 100 | 222.92 |
| 12:12 ET | 100 | 222.61 |
| 12:20 ET | 900 | 222.2006 |
| 12:23 ET | 300 | 221.9 |
| 12:25 ET | 300 | 221.935 |
| 12:27 ET | 9300 | 221.81 |
| 12:30 ET | 300 | 222.92 |
| 12:32 ET | 100 | 222.805 |
| 12:36 ET | 300 | 222.34 |
| 12:39 ET | 200 | 221.89 |
| 12:43 ET | 620 | 222.35 |
| 12:50 ET | 475 | 221.8091 |
| 12:57 ET | 300 | 222.76 |
| 12:59 ET | 500 | 222.6 |
| 01:01 ET | 500 | 222.25 |
| 01:06 ET | 400 | 221.38 |
| 01:08 ET | 500 | 221.17 |
| 01:10 ET | 300 | 220.51 |
| 01:14 ET | 100 | 220.385 |
| 01:17 ET | 1100 | 220.345 |
| 01:19 ET | 5024 | 220.43 |
| 01:21 ET | 200 | 220.53 |
| 01:24 ET | 400 | 220.66 |
| 01:26 ET | 100 | 220.32 |
| 01:28 ET | 100 | 220.41 |
| 01:30 ET | 100 | 220.45 |
| 01:32 ET | 100 | 220.415 |
| 01:35 ET | 300 | 220.11 |
| 01:37 ET | 300 | 220.04 |
| 01:42 ET | 200 | 220.05 |
| 01:44 ET | 25300 | 220.64 |
| 01:46 ET | 200 | 220.89 |
| 01:48 ET | 221 | 220.52 |
| 01:53 ET | 200 | 220.61 |
| 01:55 ET | 200 | 220.49 |
| 01:57 ET | 100 | 219.9975 |
| 02:00 ET | 500 | 220.63 |
| 02:09 ET | 341 | 220.3892 |
| 02:11 ET | 500 | 220.705 |
| 02:13 ET | 200 | 220.79 |
| 02:15 ET | 100 | 220.86 |
| 02:18 ET | 300 | 220.85 |
| 02:22 ET | 100 | 220.5 |
| 02:24 ET | 200 | 220.32 |
| 02:26 ET | 205 | 220.08 |
| 02:27 ET | 200 | 220.09 |
| 02:29 ET | 700 | 219.9675 |
| 02:31 ET | 404 | 220.52 |
| 02:40 ET | 957 | 220.81 |
| 02:42 ET | 200 | 221.11 |
| 02:44 ET | 100 | 220.995 |
| 02:45 ET | 100 | 220.68 |
| 02:47 ET | 100 | 220.71 |
| 02:51 ET | 100 | 220.57 |
| 02:54 ET | 200 | 220.26 |
| 02:56 ET | 100 | 220.36 |
| 02:58 ET | 500 | 220.31 |
| 03:00 ET | 273 | 220.47 |
| 03:02 ET | 1400 | 220.885 |
| 03:03 ET | 200 | 220.92 |
| 03:05 ET | 200 | 220.995 |
| 03:07 ET | 300 | 221.47 |
| 03:12 ET | 300 | 221.74 |
| 03:18 ET | 799 | 221.78 |
| 03:20 ET | 100 | 222.0375 |
| 03:21 ET | 700 | 222.24 |
| 03:23 ET | 200 | 222.515 |
| 03:25 ET | 200 | 222.585 |
| 03:27 ET | 400 | 222.38 |
| 03:32 ET | 300 | 222.23 |
| 03:34 ET | 694 | 222.41 |
| 03:38 ET | 300 | 222.555 |
| 03:39 ET | 100 | 222.65 |
| 03:41 ET | 500 | 222.37 |
| 03:43 ET | 1617 | 223.2 |
| 03:45 ET | 100 | 223.45 |
| 03:48 ET | 400 | 223.4 |
| 03:50 ET | 2040 | 222.965 |
| 03:52 ET | 2119 | 222.46 |
| 03:54 ET | 2577 | 222.435 |
| 03:56 ET | 2433 | 222.075 |
| 03:57 ET | 4181 | 222.735 |
| 03:59 ET | 6814 | 222.51 |
Today
May 10, 2024
DJ Madrigal Pharmaceuticals Is Maintained at Neutral by B. Riley Securities, from 8:55AM ET on Friday May 10, 2024 by Dow Jones
8:55AM ET on Friday May 10, 2024 by Dow Jones
May 8, 2024
DJ Madrigal Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co., from 3:42PM ET on Wednesday May 08, 2024 by Dow Jones
3:42PM ET on Wednesday May 08, 2024 by Dow JonesDJ Madrigal Pharmaceuticals Is Maintained at Buy by Citigroup, from 3:27PM ET on Wednesday May 08, 2024 by Dow Jones
3:27PM ET on Wednesday May 08, 2024 by Dow JonesDJ Madrigal Pharmaceuticals Is Maintained at Market Outperform by JMP Securities, from 2:10PM ET on Wednesday May 08, 2024 by Dow Jones
2:10PM ET on Wednesday May 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Madrigal Pharmaceuticals Inc | 4.8B | -9.6x | --- |
Immunitybio Inc | 4.6B | -6.1x | --- |
Nuvalent Inc | 4.3B | -27.4x | --- |
BridgeBio Pharma Inc | 5.2B | -8.6x | --- |
Krystal Biotech Inc | 4.5B | 83.1x | --- |
Immunovant Inc | 4.1B | -16.2x | --- |
Company Information
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Contact Information
- Headquarters
- 200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
- Phone
- 404-380-9263
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Julian Baker
- President, Chief Executive Officer, Director
- Bill Sibold
- Chief Financial Officer, Senior Vice President
- Mardi Dier
- President of Research and Development, Chief Medical Officer, Director
- Rebecca Taub
- Senior Vice President, General Counsel
- Brian Lynch
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.8B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 21.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.42 |
EPS | $-23.08 |
Book Value | $20.39 |
P/E Ratio | -9.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
